Aurinia Pharmaceuticals Inc.
AUPH
$15.19
$0.281.88%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 77.84M | 60.64M | 39.85M | 5.75M | -22.55M |
| Total Depreciation and Amortization | 19.45M | 19.48M | 19.45M | 19.45M | 19.53M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.62M | 20.75M | 13.75M | 13.74M | 29.21M |
| Change in Net Operating Assets | 7.20M | -8.17M | -8.76M | 5.45M | 2.40M |
| Cash from Operations | 120.10M | 92.68M | 64.29M | 44.39M | 28.59M |
| Capital Expenditure | -461.00K | -256.00K | -286.00K | -281.00K | -299.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 43.67M | 46.67M | 21.35M | 39.54M | -5.92M |
| Cash from Investing | 43.21M | 46.41M | 21.06M | 39.26M | -6.22M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12.68M | -12.19M | -11.98M | -11.99M | -15.50M |
| Issuance of Common Stock | 20.91M | 19.32M | 18.93M | 15.16M | 10.49M |
| Repurchase of Common Stock | -135.49M | -126.63M | -90.32M | -52.27M | -26.61M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -127.27M | -119.50M | -83.38M | -49.09M | -31.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.05M | 19.60M | 1.97M | 34.56M | -9.26M |